Altai Protocol Library New Indication: Darolutamide in Androgen Receptor Positive Salivary Gland Carcinoma U. Darda Bayraktar, MD 2026-08-20
Altai Protocol Library New Protocol: Atezolizumab with FOLFOX and Bevacizumab for Metastatic MSI-H Colorectal Cancer U. Darda Bayraktar, MD 2026-08-20
Altai Protocol Library New Protocol: Belzutifan with Lenvatinib for Advanced Clear Cell RCC U. Darda Bayraktar, MD 2026-08-20
Altai Protocol Library New Reference: Switching to Camizestrant at ESR1 Mutation Emergence in Breast Cancer U. Darda Bayraktar, MD 2026-08-20
Altai Protocol Library New Indication: Dabrafenib + Trametinib for bRAF V600E Mutated Differentiated Thyroid Cancer U. Darda Bayraktar, MD 2026-08-20
Altai Protocol Library New Reference: Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer U. Darda Bayraktar, MD 2026-08-20
Altai Protocol Library New Reference: Long-Term Results of Enzalutamide for Metastatic Castration-Sensitive Prostate Cancer U. Darda Bayraktar, MD 2026-08-20
Altai Protocol Library New Reference: Long-Term Results for Nivolumab in Advanced Esophageal SCC U. Darda Bayraktar, MD 2026-08-20
Altai Protocol Library New Indication: First-Line Pemigatinib for FGFR2 Rearranged Cholangiocarcinoma U. Darda Bayraktar, MD 2026-08-20
Altai Protocol Library New Reference: Rituximab Maintenance for Mantle Cell Lymphoma U. Darda Bayraktar, MD 2026-08-20
